Meyka AI API is live for developers.Start building.
Advertisement
RayzeBio, Inc. Common Stock

RayzeBio, Inc. Common Stock (RYZB) Stock Overview

Explore RayzeBio, Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.

RYZB●NASDAQ
HealthcareBiotechnology
$62.49
$0.01(0.02%)
U.S. Market opens in 57h 32m
Advertisement

RayzeBio, Inc. Common Stock (RYZB)

Meyka AI Score

Z

Key Financials

Market Cap3.8B
P/E Ratio-35.73
EPS (TTM)$-1.08
ROE0.83%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$305.20

RYZB Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of RayzeBio, Inc. Common Stock (RYZB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $305.20.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -35.73 and a market capitalization of 3.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
104.42%
6-Month Change
218.50%
Year-to-Date (YTD) Change
0.87%
1-Year Change
160.38%
3-Year Change
160.38%
5-Year Change
160.38%
All-Time (Max) Change
160.38%

Contact Information

NaN
NaN
NaN, NaN, DE, NaN

Company Facts

880 Employees
IPO DateSep 15, 2023
CountryUS

Frequently Asked Questions